IFN-γ mediates the rejection of haematopoietic stem cells in IFN-γR1-deficient hosts
2008

How IFN-γ Causes Rejection of Stem Cell Transplants in Certain Patients

publication Evidence: high

Author Information

Author(s): Martin Rottman, Claire Soudais, Guillaume Vogt, Laure Renia, Jean-François Emile, Hélène Decaluwe, Jean-Louis Gaillard, Jean-Laurent Casanova

Primary Institution: Laboratoire de Génétique Humaine des Maladies Infectieuses, INSERM, U550, Paris, France

Hypothesis

Is high serum IFN-γ concentration responsible for graft rejection in IFN-γR1-deficient hosts?

Conclusion

High serum IFN-γ concentration is necessary and sufficient for graft rejection in IFN-γR1-deficient mice.

Supporting Evidence

  • IFN-γ levels were high in Ifngr1−/− mice infected with BCG before HSCT.
  • Transplantation was successful in Ifngr1−/− × Ifng−/− double-mutant mice, even after BCG infection.
  • Efficient antibody-mediated IFN-γ depletion allowed subsequent engraftment in infected Ifngr1−/− mice.

Takeaway

This study found that too much of a certain protein, IFN-γ, in the blood can stop stem cell transplants from working in mice that lack a specific receptor. This might help doctors figure out how to make transplants work better for people with similar issues.

Methodology

The study used a mouse model to investigate the effects of IFN-γ on HSCT rejection, including various experimental infections and treatments.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Statistical Information

P-Value

p ≤ 0.007

Statistical Significance

p ≤ 0.007

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050026

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication